Technical Analysis for CNTG - Centogene N.V.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.37 | -1.60% | -0.01 |
CNTG closed down 1.6 percent on Friday, May 24, 2024, on 27 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 29
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -1.60% | |
Calm After Storm | Range Contraction | -1.60% | |
Doji - Bearish? | Reversal | -1.60% | |
Outside Day | Range Expansion | -1.60% |
Alert | Time |
---|---|
Down 2 % | 3 days ago |
Down 1% | 3 days ago |
Up 2% | 3 days ago |
Up 1% | 3 days ago |
10 DMA Support | 4 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/29/2024
Centogene BV is a commercial-stage company. It focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following two segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment provides services to pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring. The Diagnostics segment provides targeted genetic sequencing and diagnostics services. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Pharmaceutical Rare Diseases Biomarkers Recruitment Pharmaceutical Partners Diagnostics Services
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Pharmaceutical Rare Diseases Biomarkers Recruitment Pharmaceutical Partners Diagnostics Services
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.98 |
52 Week Low | 0.3457 |
Average Volume | 193,677 |
200-Day Moving Average | 0.95 |
50-Day Moving Average | 0.53 |
20-Day Moving Average | 0.41 |
10-Day Moving Average | 0.39 |
Average True Range | 0.05 |
RSI (14) | 34.64 |
ADX | 20.15 |
+DI | 19.82 |
-DI | 17.72 |
Chandelier Exit (Long, 3 ATRs) | 0.40 |
Chandelier Exit (Short, 3 ATRs) | 0.50 |
Upper Bollinger Bands | 0.46 |
Lower Bollinger Band | 0.35 |
Percent B (%b) | 0.2 |
BandWidth | 27.75 |
MACD Line | -0.04 |
MACD Signal Line | -0.05 |
MACD Histogram | 0.0063 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.40 | ||||
Resistance 3 (R3) | 0.40 | 0.40 | 0.40 | ||
Resistance 2 (R2) | 0.40 | 0.39 | 0.40 | 0.40 | |
Resistance 1 (R1) | 0.39 | 0.38 | 0.38 | 0.38 | 0.39 |
Pivot Point | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 |
Support 1 (S1) | 0.37 | 0.37 | 0.36 | 0.36 | 0.35 |
Support 2 (S2) | 0.36 | 0.37 | 0.36 | 0.35 | |
Support 3 (S3) | 0.35 | 0.36 | 0.35 | ||
Support 4 (S4) | 0.35 |